PLAUR and breast cancer: This suggestion is well supported by studies done by Li et al., [157] who found that downregulation of HER2/uPAR individually at the cell surface, leads to decreased ERK activity and this effect maximizes upon downregulation of both receptors simultaneously indicating a synergistic effect on BC cells.